Factors such as increasing manufacturing capacities and capabilities are enhancing supply capacity to meet surging global demand for these therapies
Always verify benefits directly with your insurer or through GoalBMI Wellness insurance verification before starting treatment
Higher-end projections are generally associated with cases involving confirmed, severe diagnoses, repeated emergency care, hospitalization, surgical intervention, or lasting disability, while lower-end projections tend to involve less intensive treatment or shorter symptom duration
Retatrutide is investigational and targets GLP-1, GIP, and glucagon receptors
Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, for People with Type 2 Diabetes: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial. The New England Journal of Medicine
So, it's not all about weight, it's not all about blood sugar, she said